We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Becton Dickinson
BDX
$43.1B
| $29.8M | 0.08% |
+142,790
| New | +$29.9M |
|
302
Bausch Health
BHC
$1.65B
| $29.7M | 0.08% |
1,428,418
+1,409,100
| +7,294% | +$22.3M |
|
303
W.W. Grainger
GWW
$65.3B
| $29.7M | 0.08% |
125,528
-49,427
| -28% | -$10.2M |
|
304
Expedia Group
EXPE
$31.2B
| $29.4M | 0.08% |
245,863
-62,157
| -20% | -$8.07M |
|
|
PRMW
305
DELISTED
Primo Water Corporation
PRMW
| $29.4M | 0.08% |
1,764,595
+1,725,224
| +4,382% | +$27.7M |
|
306
CenterPoint Energy
CNP
$29.1B
| $29.3M | 0.08% |
1,033,616
-508,566
| -33% | -$14.8M |
|
307
Ventas
VTR
$48.9B
| $29.1M | 0.08% |
+485,171
| New | +$30.7M |
|
308
Vodafone
VOD
$34.9B
| $29M | 0.08% |
907,968
+423,968
| +88% | +$12.7M |
|
309
Insulet
PODD
$11.3B
| $28.9M | 0.08% |
418,805
+223,800
| +115% | +$14.7M |
|
310
Electronic Arts
EA
$52.4B
| $28.9M | 0.08% |
274,718
-1,662,828
| -86% | -$185M |
|
311
Lear
LEA
$7.19B
| $28.7M | 0.08% |
162,536
-95,000
| -37% | -$16.7M |
|
312
Dolby
DLB
$4.72B
| $28.6M | 0.08% |
461,420
-42,523
| -8% | -$2.57M |
|
|
313
Altria Group
MO
$122B
| $28.5M | 0.08% |
398,467
-3,485,516
| -90% | -$234M |
|
|
HA
314
DELISTED
Hawaiian Holdings, Inc.
HA
| $28.4M | 0.08% |
713,787
+184,138
| +35% | +$7.08M |
|
315
Check Point Software Technologies
CHKP
$13.3B
| $28.2M | 0.08% |
271,762
+49,737
| +22% | +$5.4M |
|
316
Advance Auto Parts
AAP
$3.37B
| $27.9M | 0.08% |
280,177
+149,400
| +114% | +$13.7M |
|
|
NEWR
317
DELISTED
New Relic, Inc.
NEWR
| $27.9M | 0.08% |
482,999
+18,700
| +4% | +$1.02M |
|
318
Murphy Oil
MUR
$5.58B
| $27.9M | 0.08% |
897,825
+455,286
| +103% | +$12.7M |
|
319
Boston Beer
SAM
$1.88B
| $27.8M | 0.08% |
145,679
+52,885
| +57% | +$9.45M |
|
320
TransUnion
TRU
$14.8B
| $27.8M | 0.08% |
506,492
+466,398
| +1,163% | +$24.8M |
|
321
Oracle
ORCL
$331B
| $27.8M | 0.08% |
588,484
+518,300
| +738% | +$25.4M |
|
|
CHL
322
DELISTED
China Mobile Limited
CHL
| $27.8M | 0.08% |
550,500
+140,100
| +34% | +$7.05M |
|
323
Sony
SONY
$123B
| $27.8M | 0.07% |
3,090,265
+1,640,000
| +113% | +$14.1M |
|
|
K
324
DELISTED
Kellanova
K
| $27.8M | 0.07% |
435,218
+96,170
| +28% | +$5.79M |
|
325
TSMC
TSM
$2.09T
| $27.6M | 0.07% |
697,000
+56,800
| +9% | +$2.3M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.